6 results
Current guidelines for outpatient treatment of Community Acquired Pnemonia (CAP)

#Management #Outpatient #CAP #Community #Acquired #Pneumonia #Antibiotics
guidelines for outpatient ... Community Acquired Pnemonia ... #Outpatient #CAP ... Community #Acquired #Pneumonia ... #Antibiotics #Treatment
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... Community-Acquired Pneumonia ... #Acquired #Pneumonia ... #Antibiotics #Treatment ... Management #Guidelines #pharmacology
Antibiotic treatment durations for first line antibiotics recommended by Public Health England (PHE) guidance
 • Acute
Antibiotic treatment ... Community acquired pneumonia ... Community acquired pneumonia ... #primarycare #outpatient ... #treatment #pharmacology
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... Severe cryptococcal pneumonia ... #Pharmacology #Antibiotics ... #Flutycosine #Antifungal
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
(CAP) - Diagnosis ... Obtain in severe CAP ... ranging from 2% (outpatients ... 96.1% • Empiric antibiotic ... #CAP #Diagnosis
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
Azithromycin - Antibiotics ... community-acquired pneumonia ... Ceftriaxone for CAP ... #Pharmacology #Antibiotics